Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
Federal PolicyJune 26, 2026

CMS Prioritizes IRA Implementation and PBM Reform in Drug Pricing Agenda

The Trump administration has placed drug pricing at the top of its health policy agenda, with CMS focusing on implementing Inflation Reduction Act provisions and pursuing pharmacy benefit manager reforms. The agency is working on Medicare price negotiation, inflation rebates, and Part D redesign while exploring PBM transparency and reform measures. These initiatives affect how Medicaid managed care organizations negotiate drug prices, manage pharmacy benefits, and coordinate with Medicare for dual-eligible beneficiaries. The timeline for specific regulatory actions remains under development.

Why it mattersMedicaid MCOs must align pharmacy benefit management strategies with evolving federal drug pricing rules, particularly for dual-eligible populations where Medicare and Medicaid coverage intersect.

Pharmacy · Managed Care · Finance

Read the full article at jdsupra.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.